ADHD Prescribing Practices Come Under Question
National Association of Boards of Pharmacy
JUNE 6, 2022
Their availability is at least in part due to Drug Enforcement Administration’s (DEA’s) March 2020 decision to loosen remote prescribing restrictions for Schedule III through Schedule V controlled substances (CS) for the duration of the public health emergency.
Let's personalize your content